Quantitation of DNA reactive pyrrolic metabolites of senecionine - A carcinogenic pyrrolizidine alkaloid by LC/MS/MS analysis

被引:17
|
作者
Xia, Qingsu [1 ]
He, Xiaobo [1 ]
Shi, Qiang [1 ]
Lin, Ge [2 ]
Fu, Peter P. [1 ]
机构
[1] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[2] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China
关键词
Pyrrolizidine alkaloid; Senecionine; Pyrrolic metabolites; Carcinogenicity; LC/MS/MS analysis; C-14; MONOCROTALINE; LIVER; ADDUCTS; ACTIVATION; 7-CYSTEINE-PYRROLE; CONJUGATE; TOXICITY; PLANTS;
D O I
10.1016/j.jfda.2019.12.001
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Pyrrolizidine alkaloids (PAs) are carcinogenic phytochemicals, inducing liver tumors in experimental rodents. We previously determined that (+/-)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine (DHP), 7-glutathione-DHP, 7-cysteine-DHP, 7-N-acetylcysteine-DHP, and 1-CHO-DHP are DNA reactive pyrrolic metabolites potentially associated with PA-induced liver tumor initiation. In this study, we developed an LC/MS/MS multiple reaction monitoring (MRM) mode method to identify and quantify these metabolites formed from the metabolism of senecionine, a carcinogenic PA, by mouse, rat, and human liver microsomes, and primary rat hepatocytes. Together with the chemically prepared standards of these metabolites, this represents an accurate and convenient LC/MS/MS analytical method for quantifying these five reactive pyrrolic metabolites in biological systems. Copyright (C) 2019, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 50 条
  • [21] APPLICATION OF LC/MS IN THE ANALYSIS OF EXPLOSIVES AND THEIR METABOLITES
    YINON, J
    HWANG, HG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1985, 189 (APR-): : 87 - ANYL
  • [22] LC-MS analysis of lignan metabolites
    Muir, AD
    Ballantyne, K
    Reschny, K
    Westcott, ND
    PROCEEDINGS OF THE 58TH FLAX INSTITUTE OF THE UNITED STATES, 2000, : 33 - 38
  • [23] QUANTITATION OF THC AND METABOLITES IN WHOLE BLOOD BY LC-MS/MS FOR PER SE LAW TESTING
    Taylor, Adrian
    Tran, Diana
    He, Xiang
    Blethen, Tracy
    Kopp, Kevin
    Kopp, Matt
    Wang, Alexandre
    Liu, Hua-Fen
    FORENSIC SCIENCE INTERNATIONAL, 2017, 277 : 244 - 244
  • [24] LC-MS/MS assay for the quantitation of FdCyd and its metabolites FdUrd and FU in human plasma
    Holleran, Julianne L.
    Eiseman, Julie L.
    Parise, Robert A.
    Kummar, Shivaani
    Beumer, Jan H.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 129 : 359 - 366
  • [25] LC/MS/MS quantitation of arachidonic acid EET and DHET metabolites in rat urine by direct injection
    Joseph, David
    Ahlberg, Jennifer
    Spero, Denice
    Ridgewell, Richard
    DRUG METABOLISM REVIEWS, 2006, 38 : 30 - 30
  • [26] Enhancing pyrrolizidine alkaloid separation and detection: LC-MS/MS method development and integration of ion mobility spectrometry into the LC-HRMS workflow
    Carbonell-Rozas, Laura
    Dreolin, Nicola
    Foddy, Henry
    Dall'Asta, Chiara
    JOURNAL OF CHROMATOGRAPHY A, 2025, 1748
  • [27] Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC–ESI–MS/MS
    Mohamed W. Attwa
    Adnan A. Kadi
    Hany W. Darwish
    Sawsan M. Amer
    Nasser S. Al-shakliah
    Chemistry Central Journal, 12
  • [28] Detection and characterization of olmutinib reactive metabolites by LC-MS/MS: Elucidation of bioactivation pathways
    Attwa, Mohamed W.
    Kadi, Adnan A.
    Abdelhameed, Ali S.
    JOURNAL OF SEPARATION SCIENCE, 2020, 43 (04) : 708 - 718
  • [29] Analysis of the in vitro digestion of modified DNA to oligonucleotides by LC-MS and LC-MS/MS
    Andrews, CL
    Harsch, A
    Vouros, P
    INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, 2004, 231 (2-3) : 169 - 177
  • [30] Analysis of 10 urinary BTEX metabolites using LC-MS/MS
    Kohn, Elkana
    Barchel, Dana
    Golik, Ahuva
    Lougassi, Marc
    Wainstock, Tamar
    Berkovitch, Matitiahu
    Schwartsburd, Frieda
    BIOMEDICAL CHROMATOGRAPHY, 2022, 36 (04)